1. Weight loss and health status 10 years after laparoscopic adjustable gastric band insertion in adolescents: a follow-up report from Teen-LABS.
- Author
-
Fleming MA 2nd, Jenkins TM, Inge TH, Fenchel M, Boles RE, Courcoulas A, and Michalsky MP
- Subjects
- Humans, Adolescent, Female, Male, Prospective Studies, Follow-Up Studies, Young Adult, Body Mass Index, Gastroplasty methods, Gastroplasty adverse effects, Weight Loss physiology, Quality of Life, Laparoscopy adverse effects, Laparoscopy methods, Pediatric Obesity surgery, Obesity, Morbid surgery, Health Status
- Abstract
Background: Metabolic and bariatric surgery is a safe and effective treatment strategy for severe childhood obesity, affecting 10% of US adolescents., Objectives: This prospective observational study addresses knowledge gaps related to changes in weight, cardiometabolic risk, and weight-related quality of life (WRQOL) in adolescents 10 years after laparoscopic adjustable gastric band (LAGB) insertion., Setting: Five Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) US centers., Methods: Anthropometric, micronutrient, cardiometabolic risk, and WRQOL data were collected on 274 adolescents undergoing metabolic and bariatric surgery, of which 14 participants underwent LAGB insertion (2008-2011). Descriptive analyses compared outcomes from baseline to 10 years., Results: Participants were mostly female (86%), White (71%), with a median age of 18.5 years and preoperative median BMI of 49. Baseline prevalence of type 2 diabetes, hypertension, and dyslipidemia were 1 of 14 (7%), 8 of 14 (57%), and 8 of 13 (62%), respectively, versus 10-year prevalence of 1 of 8 (13%), 4 of 10 (40%), and 3 of 9 (33%), respectively. Two participants underwent LAGB removal (years 2 and 3), whereas two converted from LAGB to Roux-en-Y gastric bypass (years 2 and 6). Following initial BMI reduction (-10%) at year 1, 10-year median BMI in the LAGB retention group was 51, representing a 9.2% increase versus baseline. Micronutrient abnormalities and WRQOL remained similar between baseline and 10 years. One participant (1 of 14) withdrew from the study at year 7., Conclusions: Long-term follow-up of this cohort reveals that LAGB had minimal impact on BMI, cardiometabolic risk factors, and WRQOL among adolescents. These results confirm the limited efficacy of LAGB in the pediatric population., Competing Interests: Disclosures Dr. Michalsky has received educational honoraria from Intuitive Surgical, Inc., unrelated to this project. Dr. Courcoulas has a grant from Allurion Technologies, outside the scope of this work. Dr. Inge has received consulting fees from Standard Bariatrics, Teleflex, Medtronic, Mediflix, Independent Medical Expert Consulting Services, and royalties from Wolters Kluwer (UpToDate) all unrelated to this project. Funding for Teen-LABS was provided by the National Institutes of Health (NIH) U01DK072493, UM1DK072493, and UM1DK095710., (Copyright © 2025 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF